The Assessment of Uncertainty in Measurement of Cholesterol: A Model of Calculation  by Udristioiu, Aurelian
504a Tuesday, March 3, 2009the thin filament, whereas the dilated cardiomyopathy mutations
(TnTR141W and TnTdeltaK210) accelerated the rate of Ca2þ dissociation
from the thin filament. The Ca2þ sensitizing compound bepridil had no
effect on the rate of Ca2þ dissociation in either thin filaments or myofi-
brils, but engineered mutations of TnC can accelerate or slow the rate.
Finally, the alpha and beta isoforms of tropomyosin slowed and accelerated
the rate of Ca2þ dissociation from the thin filament, respectively. Thus,
multiple factors can modulate the rate of Ca2þ dissociation from the thin
filament.
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Ca2þ induces structural transitions within the cardiac thin filament. The struc-
tural kinetics at the troponin-actin interface was investigated by Fo¨rster Res-
onance Energy Transfer (FRET) to understand the molecular basis underlying
thin filament regulation. The kinetics of the Ca2þ-induced conformational
changes at the cTnC N-domain, the cTnC-cTnI and the cTnI-actin interfaces
were studied. The structural transition of the cTnC N-domain was examined
by monitoring FRET between a donor (AEDANS) attached to one cysteine
and an acceptor (DDPM) attached the other cysteine mutant of cTnC(13C/
51C). The cTnC-cTnI interactions were investigated by monitoring the dis-
tance changes from cTnC(89C) to cTnI(151C) and cTnI(167C). Both
cTnI(151C) and cTnC(167C) were labeled with AEDANS as FRET donor
and cTnC(89C) was labeled with DDPM as the FRET acceptor. These two
labeled cTnI mutants were also used to monitor Ca2þ-induced distance
changes from cTnI residues 151 and 167 to the cysteine residue 374 of actin
labeled with DABM as the FRET acceptor. Results from FRET Ca2þ titra-
tions and stopped-flow kinetic measurements demonstrated that different
structural transitions have different Ca2þ sensitivities and different Ca2þ dis-
sociation-induced kinetics. Structural transitions involving the regulatory re-
gion and the mobile domain of cTnI occurred at fast kinetic rates, while the
structural transitions involving transversal movement of the cTnI inhibitory
region occurred at slow kinetic rates. Our results suggest a two-step deacti-
vation of the thin filament upon Ca2þ dissociation. The first step may involve
rapid binding of the mobile domain of cTnI to actin, which was kinetically
coupled with the conformational change of cTnC N-domain and dissociation
of the regulatory region of cTnI from the cTnC hydrophobic pocket. The sec-
ond step involved the inhibitory region of cTnI switching its interacting from
cTnC to actin. The latter processes may participate in regulating crossbridge
kinetics.
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Tropomyosin (TM) is involved in calcium mediated muscle contraction and
relaxation in the heart. Striated muscle alpha TM is the major isoform ex-
pressed in the heart. Expression of striated muscle beta TM in murine myo-
cardium results in a decreased rate of relaxation and increased myofilament
calcium sensitivity. Replacing the carboxyl terminus (amino acids 258-284)
of alpha TM for beta TM (a troponin-T [TnT] binding region) results in
decreased rates of contraction and relaxation in the heart and decreased
myofilament calcium sensitivity. We hypothesized that the putative internal
TnT binding domain (amino acids 175-190) of beta TM may be responsible
for the increased myofilament calcium sensitivity observed when the entire
beta TM is expressed in the heart. To test this hypothesis, we generated
transgenic mice that express a chimeric TM containing beta TM amino
acids 175-190 in the backbone of alpha TM (amino acids 1-174 and
191-284). These mice express 16% - 57% chimeric TM, and they do not
develop cardiac hypertrophy or any other morphological changes. Physio-
logical analysis shows these hearts exhibit systolic and diastolic dysfunction
and a positive response to isoproterenol. Skinned fiber bundle analyses
show a significant increase in myofilament calcium sensitivity. Biophysical
studies demonstrate that the exchanged amino acids do not influence the
flexibility of TM. This is the first study to demonstrate that a specific do-main within TM can increase calcium sensitivity of the thin filament. Fur-
ther, these results enhance the understanding of why TM mutations associ-
ated with familial hypertrophic cardiomyopathy also demonstrate increased
myofilament sensitivity to calcium.
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The objective of this work was to identify all the components of uncertainty in
measurement of Cholesterol, undergoing a reasonable estimation of results in
the acceptable method.
Material and Method:
For identification of the uncertainty in measurement of Cholesterol in labora-
tory, running Hitachi 912 Roche Analyzer, was necessary the Standard Choles-
terol (ST).
Results:
Was calculated, in function of Standard Deviation (SD) and Student Factor (t),
by estimation (SD * t), Compound Uncertainty of ST, assembling Uncertainty
of A type and Uncertainty of B type, in value of 11 mg%.
Conclusion:
Budget of Uncertainty, in assessment of Cholesterol was established to a per-
mitted error of 11% in normal range and under cut-off.Microtubules & Microtubule-associated Proteins
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Kinesin belongs to a class of microtubule (MT) based molecular motors, which
can facilitate the intracellular transport of vesicle bound cargo and organelles
throughout the cell. This vital function is especially pronounced in the neuron,
where transport down exceedingly long processes, such as axons and dendrites,
must be efficiently accomplished and cannot be explained be diffusion alone.
Like most cellular processes, regulation is a fundamental aspect of kinesin me-
diated intracellular trafficking and to date many modes to regulate kinesin have
been elicited. Recently the microtubule associated protein (MAP), tau, has been
implicated in playing a central role in the regulation of kinesin mediated trans-
port in the neuron. Tau has previously been shown to reduce the procesivity and
attachment frequency of kinesin motors on MTs. Although it has been demon-
strated that tau has a dramatic affect on kinesin based transport, the mechanism
by which this occurs is presently unknown. Using stopped-flow rapid kinetics,
we demonstrate that tau directly affects the on-rate of kinesin for MTs causing
the motor to dissociate from the MT track. Because kinesin releases ADP at
a greatly accelerated rate in the presence of MTs, we can effectively monitor
the on-rate of kinesin for MTs by following the release of the fluorescent
ADP analog mantADP. We demonstrate the on-rate of kinesin, for MTs, is re-
duced by tau in both a concentration and isoform specific manner.
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